These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 6663608

  • 1. Solubilization of immune complexes and inhibition of immune precipitation in SLE sera.
    Balestrieri G, Pagani D, Tincani A.
    J Clin Lab Immunol; 1983 Nov; 12(3):147-50. PubMed ID: 6663608
    [Abstract] [Full Text] [Related]

  • 2. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T, Fujita T, Kono I, Kabashima T, Yamane K, Tamura N, Kashiwagi H.
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [Abstract] [Full Text] [Related]

  • 3. Complement activation and impaired capacity to solubilize immune complexes or to prevent their formation in essential mixed cryoglobulinemia.
    Corvetta A, Spaeth PJ, Ghirelli PA, Orecchioni F, Buetler R, Montroni M, Nydegger UE.
    Diagn Immunol; 1983 Apr; 1(4):315-23. PubMed ID: 6333960
    [Abstract] [Full Text] [Related]

  • 4. Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus.
    Adu D, Williams DG.
    Clin Exp Immunol; 1984 Mar; 55(3):495-501. PubMed ID: 6705265
    [Abstract] [Full Text] [Related]

  • 5. Complement-mediated solubilization in patients with systemic lupus erythematosus, nephritis or vasculitis.
    Schifferli JA, Morris SM, Dash A, Peters DK.
    Clin Exp Immunol; 1981 Dec; 46(3):557-64. PubMed ID: 7337980
    [Abstract] [Full Text] [Related]

  • 6. C4A deficiency and elevated level of immune complexes: the mechanism behind increased susceptibility to systemic lupus erythematosus.
    Traustadottir KH, Sigfusson A, Steinsson K, Erlendsson K.
    J Rheumatol; 2002 Nov; 29(11):2359-66. PubMed ID: 12415592
    [Abstract] [Full Text] [Related]

  • 7. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
    Baatrup G, Jonsson H, Sjöholm A, Sturfelt G, Svehag SE.
    J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
    [Abstract] [Full Text] [Related]

  • 8. The effect of sera of patients with systemic lupus erythematosus on artificial immune complexes.
    Bányai A, Szabó G, Csongor J, Sonkoly I, Szegedi G.
    Acta Med Hung; 1985 Jun; 42(1-2):51-7. PubMed ID: 4034337
    [Abstract] [Full Text] [Related]

  • 9. A longitudinal study of circulating immune complexes, dna antibodies and complement in patients with systemic lupus erythematosus: an analysis of their relationship to disease activity.
    Harkiss GD, Hazleman BL, Brown DL.
    J Clin Lab Immunol; 1979 Nov; 2(4):275-83. PubMed ID: 537024
    [Abstract] [Full Text] [Related]

  • 10. Circulating immune complexes in lupus erythematosus, scleroderma and dermatomyositis.
    Sølling J, Sølling K, Jacobsen KU.
    Acta Derm Venereol; 1979 Nov; 59(5):421-6. PubMed ID: 93365
    [Abstract] [Full Text] [Related]

  • 11. Reduced complement-mediated immune complex solubilizing capacity and the presence of incompletely solubilized immune complexes in SLE sera.
    Baatrup G, Petersen I, Jensenius JC, Svehag SE.
    Clin Exp Immunol; 1983 Nov; 54(2):439-47. PubMed ID: 6652967
    [Abstract] [Full Text] [Related]

  • 12. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
    Sekita K, Doi T, Muso E, Yoshida H, Kanatsu K, Hamashima Y.
    Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422
    [Abstract] [Full Text] [Related]

  • 13. Restoration of normal interactions between immune complexes and systemic lupus erythematosus blood cells by normal serum.
    Medof ME, Oger JJ, Antel JP, Prince GM.
    J Clin Lab Immunol; 1982 Feb; 7(2):93-103. PubMed ID: 7069786
    [Abstract] [Full Text] [Related]

  • 14. DNA levels in circulating immune complexes decrease at severe SLE flares-correlation with complement component C1q.
    Bengtsson A, Nezlin R, Shoenfeld Y, Sturfelt G.
    J Autoimmun; 1999 Aug; 13(1):111-9. PubMed ID: 10441175
    [Abstract] [Full Text] [Related]

  • 15. Circulating immune complexes associated with decreased complement-mediated inhibition of immune precipitation in sera from patients with bacterial endocarditis.
    Kerr MA, Wilton E, Naama JK, Whaley K.
    Clin Exp Immunol; 1986 Feb; 63(2):359-66. PubMed ID: 3698338
    [Abstract] [Full Text] [Related]

  • 16. Mononuclear phagocyte system in SLE. II. A kinetic model of immune complex handling in systemic lupus erythematosus.
    Meryhew NL, Kimberly RP, Messner RP, Runquist OA.
    J Immunol; 1986 Jul 01; 137(1):97-102. PubMed ID: 3486919
    [Abstract] [Full Text] [Related]

  • 17. [Serum complement levels in patients with rheumatoid arthritis and vasculitis].
    Tomooka K.
    Fukuoka Igaku Zasshi; 1989 Oct 01; 80(10):456-66. PubMed ID: 2613159
    [Abstract] [Full Text] [Related]

  • 18. Specific detection of circulating DNA:anti-DNA immune complexes in human systemic lupus erythematosus sera using murine monoclonal anti-DNA antibody.
    Tron F, Letarte J, Roque-Antunes Barreira MC, Lesavre P.
    Clin Exp Immunol; 1982 Aug 01; 49(2):481-7. PubMed ID: 6982138
    [Abstract] [Full Text] [Related]

  • 19. Circulating immune complexes and the complements system in lupus nephropathy.
    Serban MG.
    Rom J Intern Med; 1992 Aug 01; 30(2):119-25. PubMed ID: 1496264
    [Abstract] [Full Text] [Related]

  • 20. Immunochemical determination of DNA in immune complexes present in the circulation of patients with systemic lupus erythematosus.
    Nezlin R, Alarcón-Segovia D, Shoenfeld Y.
    J Autoimmun; 1998 Oct 01; 11(5):489-93. PubMed ID: 9802934
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.